Mebeverine hydrochloride
Antispasmodics and other drugs altering gut motility | Gastro-Intestinal System
Items (National)
2.2M
NHS Cost
£10.5M
Practices
7,175
Avg per Practice
311
Overview
Mebeverine hydrochloride is prescribed by 7,175 GP practices across England. In the last 12 months, 2,227,879 items were prescribed at a total cost of £10,540,745 to the NHS. It is classified under BNF Chapter Gastro-Intestinal System, Section Antispasmodics and other drugs altering gut motility.
Monthly Prescribing Trend
Jun 2026
189,345
Jun 2026
177,334
Jun 2026
193,763
Jun 2026
187,086
Jun 2026
183,027
Jun 2026
192,049
Jun 2026
183,819
Jun 2026
188,157
Jun 2026
191,368
Jun 2026
166,704
Jun 2026
176,463
Jun 2026
179,985
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| S | 89.2K | 177 | 504 | +62.3% ▲ |
| NE | 79.6K | 148 | 538 | +73.2% ▲ |
| B | 72.5K | 273 | 266 | -14.4% ▼ |
| L | 55.9K | 146 | 383 | +23.4% ▲ |
| NG | 55.7K | 142 | 392 | +26.4% ▲ |
| M | 55.5K | 183 | 303 | -2.3% ▼ |
| PE | 53.2K | 97 | 548 | +76.6% ▲ |
| TS | 49.6K | 77 | 644 | +107.4% ▲ |
| DN | 49.4K | 89 | 556 | +78.9% ▲ |
| LE | 42.9K | 128 | 335 | +8.0% ▲ |
| NR | 38.5K | 75 | 513 | +65.2% ▲ |
| CV | 36.2K | 114 | 318 | +2.4% ▲ |
| PO | 35.2K | 67 | 525 | +69.1% ▲ |
| NN | 35.1K | 68 | 516 | +66.1% ▲ |
| ST | 34.9K | 87 | 401 | +29.2% ▲ |
| LS | 33.0K | 93 | 355 | +14.4% ▲ |
| WA | 32.1K | 91 | 353 | +13.8% ▲ |
| BS | 31.6K | 80 | 394 | +27.0% ▲ |
| IP | 30.2K | 63 | 480 | +54.5% ▲ |
| HU | 30.1K | 47 | 641 | +106.3% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| VALENS MEDICAL PARTNERSHIP | 3,920 |
| BAY MEDICAL GROUP | 3,148 |
| MODALITY PARTNERSHIP (HULL) | 3,031 |
BNF Classification
- Chapter: Gastro-Intestinal System
- Section: Antispasmodics and other drugs altering gut motility
- Paragraph: Antispasmodics and other drugs altering gut motility
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.